Document is current
Any future updates will be listed below
-
Authors
Kumar, Shaji https://orcid.org/0000-0001-5392-9284
Weisel, Katja C. https://orcid.org/0000-0001-9422-6614
Spin, Paul
Bonar, Nicolle
Siddiqui, Muhaimen
Shokoohi, Mostafa https://orcid.org/0000-0002-3810-752X
Wang, Di
Hou, Kevin
West, Michael E. D. https://orcid.org/0009-0000-8952-3702
Hampp, Christian https://orcid.org/0000-0002-1094-6364
Green, Jeannette
Harnett, James
Humblet, Olivier
Breskin, Alexander https://orcid.org/0000-0001-5568-2510
Ge, Wenzhen
Jalbert, Jessica J.
Sobel, Rachel E. https://orcid.org/0000-0002-4492-9562
Kroog, Glenn S. https://orcid.org/0009-0000-2897-9810
Lorenc, Karen Rodriguez
Ma, Qiufei
Jagannath, Sundar https://orcid.org/0000-0003-2934-6518
-
Funding
Funding for this research was provided by:
Regeneron Pharmaceuticals
- License Information
-
More Information
Article History
Received: 7 August 2025
Revised: 16 December 2025
Accepted: 28 January 2026
First Online: 1 April 2026
Competing interests
: CH, JG, JH, OH, AB, WG, JJJ, RES, GSK, KRL, and QM are employees and shareholders of Regeneron Pharmaceuticals, Inc. JH and RES hold shares in Pfizer Inc. PS, NB, MSi, MSh, DW, KH, and MEDW are employees of EVERSANA. EVERSANA consults for various pharmaceutical and medical device companies. SK has received consulting/advisory role fees from Takeda, Janssen Oncology, Genentech/Roche, AbbVie, Bristol Myers Squibb/Celgene, Pfizer, Regeneron Pharmaceuticals, Inc., Sanofi, and K36, travel/accommodation/expenses from AbbVie and Pfizer, and research funding from Takeda, AbbVie, Novartis, Sanofi, Janssen Oncology, MedImmune, Roche/Genentech, CARsgen Therapeutics, Allogene Therapeutics, GSK, Regeneron Pharmaceuticals, Inc., and Bristol Myers Squibb. KCW has received research grants, honoraria, and/or consulting fees from AbbVie, Amgen, Adaptive Biotech, AstraZeneca, BeiGene, Bristol Myers Squibb, Cellcentric, Janssen, GSK, Karyopharm, Novartis, Oncopeptides, Pfizer, Regeneron Pharmaceuticals, Inc., Roche Pharma, Sanofi, Stemline, and Takeda. SJ has received consulting fees from Bristol Myers Squibb, Poseida, Caribou, Genmab, Grail, GSK, Janssen, Legend Biotech, Regeneron Pharmaceuticals, Inc., Sanofi, and Takeda, and travel/accommodation/expenses from Regeneron Pharmaceuticals, Inc., IMS, Legend Biotech, and Poseida.
